Case Studies
Pediatrics Programs
Anti-Epileptic Drug
Challenge
Assessing seizure control benefit against cognitive development and growth effects in school-age children requiring long-term treatment
ArcaScience Approach
Integrated neurodevelopmental outcomes from clinical trials with growth trajectory analysis and cognitive assessment data across 1,800 pediatric patients
Results
- ✓Growth impact quantified by age group
- ✓Cognitive safety signal detection automated
- ✓PIP-compliant BRA documentation prepared
Biologic (Anti-TNF)
Challenge
Long-term immunosuppression safety in developing immune systems with limited pediatric-specific safety data
ArcaScience Approach
Pediatric safety extrapolation from adult RA data with age-stratified infection risk modeling and vaccination response monitoring
Results
- ✓Pediatric infection risk contextualized
- ✓Vaccination response impact characterized
- ✓PREA post-marketing study design supported
ADHD Stimulant Medication
Challenge
Balancing attention/behavior improvement against growth suppression, cardiovascular effects, and substance abuse potential
ArcaScience Approach
Long-term growth trajectory modeling with cardiovascular safety monitoring and behavioral outcome assessment across 3,200 pediatric patients
Results
- ✓Growth suppression trajectory predicted by age of initiation
- ✓Cardiovascular monitoring framework established
- ✓Annual PSUR generation automated
Aggregate Outcomes
Results Across Pediatrics Programs
70%+
Reduction in BRA Preparation Time
90%+
Accuracy in AE Classification
3x
Faster Regulatory Submissions
Download
Get the Full Pediatrics Case Study Collection
Complete the form below to receive the document via email.
Related Resources